NLM Digital Collections

Search

Start Over Subjects Opioid-Related Disorders ✖Remove constraint Subjects: Opioid-Related Disorders Languages English ✖Remove constraint Languages: English

2. Medicaid: what to watch in 2019 from the Administration, Congress, and the states

Author(s):
Rudowitz, Robin, author
Musumeci, MaryBeth, author
Artiga, Samantha, author
Publication:
San Francisco, CA : Henry J. Kaiser Family Foundation, January 2019
Subject(s):
Health Care Reform -- organization & administration
Medicaid -- organization & administration
Medicaid -- trends
Forecasting
Home Care Services
Insurance, Health, Reimbursement
Managed Care Programs
Opioid-Related Disorders
State Government
Substance-Related Disorders
Telemedicine
Humans
Puerto Rico
United States
United States Virgin Islands

4. The deadly drug

Author(s):
Wright, Charles E. (Charles Edward), 1843-1893
Publication:
Indianapolis : The Saturday Herald, 1879
Subject(s):
Opium
Opioid-Related Disorders

7. Prescription drug monitoring programs: evolution and evidence

Author(s):
Weiner, Janet, author
Bao, Yuhua, author
Meisel, Zachary, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, June 2017
Subject(s):
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- therapeutic use
Drug and Narcotic Control
Drug Overdose -- epidemiology
Government Programs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders
Mandatory Programs
State Government
Humans
United States

8. Putting Medicaid in the larger budget context: an in-depth look at three states in FY 2017 and FY 2018

Author(s):
Gifford, Kathleen, author
Ellis, Eileen, author
Lashbrook, Aimee, author
Valentine, Allison, author
Hinton, Elizabeth, author
Antonisse, Larisa, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, October 2017
Subject(s):
Budgets
Medicaid -- economics
Medicaid -- organization & administration
Eligibility Determination
Health Care Reform -- economics
Insurance, Health, Reimbursement -- economics
Managed Care Programs
Opioid-Related Disorders
Patient-Centered Care
State Government
Humans
Nevada
North Carolina
West Virginia
United States
United States.

10. Medicaid expansion: behavioral health treatment use in selected states in 2014 : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, June 2017
Subject(s):
Medicaid
Mental Disorders -- drug therapy
Mental Disorders -- therapy
Mental Health Services -- utilization
Analgesics, Opioid -- therapeutic use
Forecasting
Mental Health Services -- trends
Opioid-Related Disorders
Humans
Iowa
New York
Washington
West Virginia
United States
United States.

11. Newborn health: federal action needed to address neonatal abstinence syndrome : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Neonatal Abstinence Syndrome -- economics
Neonatal Abstinence Syndrome -- therapy
Infant, Newborn
Insurance Coverage -- economics
Medicaid -- economics
Mothers
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders
Patient Education as Topic
Pregnancy
Prenatal Care
Social Stigma
Substance-Related Disorders -- therapy
Humans
United States
United States. Department of Health and Human Services.

18. Breaking through the noise: the facts about the Medicaid program

Author(s):
Flinn, Brendan, author
Accius, Jean, author
Publication:
Washington, DC : AARP Public Policy Institute, October 2018
Subject(s):
Medicaid -- statistics & numerical data
Medicaid -- trends
Adult
Aged
Child
Disabled Persons
Eligibility Determination
Forecasting
Dual MEDICAID MEDICARE Eligibility
Long-Term Care
Opioid-Related Disorders
Poverty
State Government
Humans
United States

19. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

20. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)